Understanding the impact of COVID-19 on antibiotic use in Canadian primary care: a matched-cohort study using EMR data.

IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES
Rachael Morkem, Glenys Smith, Braden Knight, Sabrina T Wong, David Barber
{"title":"Understanding the impact of COVID-19 on antibiotic use in Canadian primary care: a matched-cohort study using EMR data.","authors":"Rachael Morkem, Glenys Smith, Braden Knight, Sabrina T Wong, David Barber","doi":"10.1186/s13756-024-01434-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inappropriate or overuse of antibiotic prescribing in primary care highlights an opportunity for antimicrobial stewardship (AMS) programs aimed at reducing unnecessary use of antimicrobials through education, policies and practice audits that optimize antibiotic prescribing. Evidence from the early part of the pandemic indicates a high rate of prescribing of antibiotics for patients with COVID-19. It is crucial to surveil antibiotic prescribing by primary care providers from the start of the pandemic and into its endemic stage to understand the effects of the pandemic and better target effective AMS programs.</p><p><strong>Methods: </strong>This was a matched pair population-based cohort study that used electronic medical record (EMR) data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). Participants included all patients that visited their primary care provider and met the inclusion criteria for COVID-19, respiratory tract infection (RTI), or non-respiratory or influenza-like-illness (negative). Four outcomes were evaluated (a) receipt of an antibiotic prescription; (b) receipt of a non-antibiotic prescription; (c) a subsequent primary care visit (for any reason); and (d) a subsequent primary care visit with a bacterial infection diagnosis. Conditional logistic regression was used to evaluate the association between COVID-19 and each of the four outcomes. Each model was adjusted for location (rural or urban), material and social deprivation, smoking status, alcohol use, obesity, pregnancy, HIV, cancer and number of chronic conditions.</p><p><strong>Results: </strong>The odds of a COVID-19 patient receiving an antibiotic within 30 days of their visit is much lower than for patients visiting for RTI or for a non-respiratory or influenza-like-illnesses (AOR = 0.08, 95% CI[0.07, 0.09] compared to RTI, and AOR = 0.43, 95% CI[0.38, 0.48] compared to negatives). It was found that a patient visit for COVID-19 was much less likely to have a subsequent visit for a bacterial infection at all time points.</p><p><strong>Conclusions: </strong>Encouragingly, COVID-19 patients were much less likely to receive an antibiotic prescription than patients with an RTI. However, this highlights an opportunity to leverage the education and attitude change brought about by the public health messaging during the COVID-19 pandemic (that antibiotics cannot treat a viral infection), to reduce the prescribing of antibiotics for other viral RTIs and improve antibiotic stewardship.</p>","PeriodicalId":7950,"journal":{"name":"Antimicrobial Resistance and Infection Control","volume":"13 1","pages":"76"},"PeriodicalIF":4.8000,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11242630/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial Resistance and Infection Control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13756-024-01434-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Inappropriate or overuse of antibiotic prescribing in primary care highlights an opportunity for antimicrobial stewardship (AMS) programs aimed at reducing unnecessary use of antimicrobials through education, policies and practice audits that optimize antibiotic prescribing. Evidence from the early part of the pandemic indicates a high rate of prescribing of antibiotics for patients with COVID-19. It is crucial to surveil antibiotic prescribing by primary care providers from the start of the pandemic and into its endemic stage to understand the effects of the pandemic and better target effective AMS programs.

Methods: This was a matched pair population-based cohort study that used electronic medical record (EMR) data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). Participants included all patients that visited their primary care provider and met the inclusion criteria for COVID-19, respiratory tract infection (RTI), or non-respiratory or influenza-like-illness (negative). Four outcomes were evaluated (a) receipt of an antibiotic prescription; (b) receipt of a non-antibiotic prescription; (c) a subsequent primary care visit (for any reason); and (d) a subsequent primary care visit with a bacterial infection diagnosis. Conditional logistic regression was used to evaluate the association between COVID-19 and each of the four outcomes. Each model was adjusted for location (rural or urban), material and social deprivation, smoking status, alcohol use, obesity, pregnancy, HIV, cancer and number of chronic conditions.

Results: The odds of a COVID-19 patient receiving an antibiotic within 30 days of their visit is much lower than for patients visiting for RTI or for a non-respiratory or influenza-like-illnesses (AOR = 0.08, 95% CI[0.07, 0.09] compared to RTI, and AOR = 0.43, 95% CI[0.38, 0.48] compared to negatives). It was found that a patient visit for COVID-19 was much less likely to have a subsequent visit for a bacterial infection at all time points.

Conclusions: Encouragingly, COVID-19 patients were much less likely to receive an antibiotic prescription than patients with an RTI. However, this highlights an opportunity to leverage the education and attitude change brought about by the public health messaging during the COVID-19 pandemic (that antibiotics cannot treat a viral infection), to reduce the prescribing of antibiotics for other viral RTIs and improve antibiotic stewardship.

了解 COVID-19 对加拿大初级保健中抗生素使用的影响:使用 EMR 数据进行匹配队列研究。
背景:初级医疗中抗生素处方的不当或过度使用凸显了抗菌药物管理(AMS)计划的机遇,该计划旨在通过教育、政策和实践审核来优化抗生素处方,从而减少抗菌药物的不必要使用。大流行初期的证据表明,COVID-19 患者的抗生素处方使用率很高。从疫情开始到疫情结束,对初级保健提供者的抗生素处方进行调查对于了解疫情的影响和更好地制定有效的 AMS 计划至关重要:这是一项配对人群队列研究,使用的是加拿大初级医疗哨点监测网络(CPCSSN)的电子病历(EMR)数据。参与者包括所有到初级保健提供者处就诊并符合 COVID-19、呼吸道感染 (RTI) 或非呼吸道或流感样疾病(阴性)纳入标准的患者。对四种结果进行了评估:(a) 收到抗生素处方;(b) 收到非抗生素处方;(c) 后续初级保健就诊(出于任何原因);(d) 诊断为细菌感染的后续初级保健就诊。条件逻辑回归用于评估 COVID-19 与四种结果中每种结果之间的关联。每个模型都根据地点(农村或城市)、物质和社会贫困程度、吸烟状况、饮酒、肥胖、怀孕、艾滋病、癌症和慢性病数量进行了调整:COVID-19 患者在就诊后 30 天内接受抗生素治疗的几率远低于因 RTI 或非呼吸道疾病或流感样疾病就诊的患者(与 RTI 相比,AOR = 0.08,95% CI[0.07, 0.09];与阴性患者相比,AOR = 0.43,95% CI[0.38, 0.48])。研究发现,在所有时间点上,因 COVID-19 就诊的患者随后因细菌感染就诊的可能性都要小得多:令人鼓舞的是,与 RTI 患者相比,COVID-19 患者获得抗生素处方的可能性要小得多。不过,这也凸显了一个机会,即可以利用 COVID-19 大流行期间的公共卫生信息(抗生素不能治疗病毒感染)所带来的教育和态度转变,减少其他病毒性 RTI 的抗生素处方,提高抗生素管理水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES
CiteScore
9.70
自引率
3.60%
发文量
140
审稿时长
13 weeks
期刊介绍: Antimicrobial Resistance and Infection Control is a global forum for all those working on the prevention, diagnostic and treatment of health-care associated infections and antimicrobial resistance development in all health-care settings. The journal covers a broad spectrum of preeminent practices and best available data to the top interventional and translational research, and innovative developments in the field of infection control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信